WEST PHARMACEUTICAL SERVICES, INC. Assets, Fair Value Disclosure
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Assets, Fair Value Disclosure of $190.00 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2026-07-23
- 2026-06-30: Assets, Fair Value Disclosure $190.00M.
- 2026-03-31: Assets, Fair Value Disclosure $217.10M.
- 2025-12-31: Assets, Fair Value Disclosure $520.70M.
- 2025-09-30: Assets, Fair Value Disclosure $263.10M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $190.00M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $217.10M 10-Q · filed 2026-04-23 | |
| 2025-12-31 | $520.70M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $263.10M 10-Q · filed 2025-10-23 | |
| 2025-06-30 | $235.50M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $156.90M 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $241.20M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $248.30M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $44.20M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $33.80M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $496.70M 10-K · filed 2025-02-18 | $34.20M 10-K · filed 2024-02-20 |
| 2023-09-30 | $35.00M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $36.90M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $29.40M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $32.10M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $56.70M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $56.10M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $50.90M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $36.40M 10-K · filed 2023-02-21 | |
| 2021-09-30 | $30.40M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $24.70M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $20.80M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $16.10M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $12.40M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $11.20M 10-Q · filed 2020-07-24 | |
| 2020-03-31 | $10.60M 10-Q · filed 2020-04-24 | |
| 2019-12-31 | $19.10M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $23.20M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $19.60M 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $27.10M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $15.20M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $12.20M 10-Q · filed 2018-10-30 | |
| 2017-12-31 | $9.40M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |